Promoting the quality of medicines plus (PQM+) program

Ended Cooperative Agreement Awarded Last action

Award ID
7200AA19CA00025
Recipient
Awarding agency
Obligated
$2,601,036,704

Award facts

Completion date
Originally
Funding
  • $440,559,682.00 Federal
  • $2,160,477,022.00 Non-federal
Funding agency
Bureau for Global Health Washington Office, US Agency for International Development
Place of performance
Kenya

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $2,547,000 $0
Amendment $1,164,625 $0
Amendment $1,164,625 $0
Amendment $600,000 $0
Amendment $600,000 $0
Amendment $600,000 $0
Amendment $1,265,000 $0
Amendment $1,265,000 $0
Amendment $1,265,000 $0
Amendment $1,265,000 $0
Amendment $2,900,000 $0
Amendment $2,900,000 $0
Amendment $2,900,000 $0
Amendment $2,900,000 $0
Amendment $2,900,000 $0
Amendment $4,712,700 $0
Amendment $4,712,700 $0
Amendment $4,712,700 $0
Amendment $4,712,700 $0
Amendment $4,712,700 $0
Amendment $6,730,255 $0
Amendment $6,730,255 $0
Amendment $6,730,255 $0
Amendment $6,730,255 $0
Amendment $6,730,255 $0
Amendment $2,250,000 $0
Amendment $2,250,000 $0
Amendment $2,250,000 $0
Amendment $2,250,000 $0
Amendment $2,250,000 $0
Amendment $2,250,000 $0
Amendment $1,402,000 $0
Amendment $1,402,000 $0
Amendment $1,402,000 $0
Amendment $1,402,000 $0
Amendment $1,402,000 $0
Amendment $1,402,000 $0
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $130,000 $16,000,000
Amendment $1,378,000 $16,000,000
Amendment $1,378,000 $16,000,000
Amendment $1,378,000 $16,000,000
Amendment $1,378,000 $16,000,000
Amendment $1,378,000 $16,000,000
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Virginia Commonwealth University VCU will design, develop, and pilot novel and alternative synthetic route(s) to address primary cost drivers and remove Rifapentine carryover to subsequent… $3,146,716
Panagora Group Inc. Panagora is USP's partner on the PQM+ Program to provide systems and processes for monitoring, evaluation, and learning across the program and facilitate… $4,004,249
Purdue University The purpose of this subaward is to leverage Howard University’s technical expertise as a PQM+ Technical Resource Partner to support the implementation of… $463,038
Intrahealth International, Inc. In collaboration with USP and the PQM+ consortium, IntraHealth will support PQM+�s capacitybuilding strategy which is focused on meeting USAID�s… $1,841,376
Muhimbili University Of Health And Allied Sciences MUHAS will contribute to PQM+ Objectives 2 and 4 and provide support to quality management systems (QMS), good manufacturing practices (GMP), and laboratory… $134,950
University Of Washington By leveraging the technical expertise and experience in research and modeling, medicine regulatory systems, and curriculum development in medicine quality… $295,542
Subrecipient not on record To conduct a bioequivalence study of 2 FDC for Isoniazid/Rifampicin, 75mg/150mg tablet. $76,930
Subrecipient not on record Study of Praziquantel $100,000
Subrecipient not on record To apply the risk based approach of sampling and testing of medicines. $39,084
Howard University The purpose of this subaward is to leverage Howard University’s technical expertise as a PQM+ Technical Resource Partner to support the implementation of… $44,442
Mahidol University Landscapre survey analysis for NTD medical products $117,079
University Of Washington By leveraging the technical expertise and experience in research and modeling, medicine regulatory systems, and curriculum development in medicine quality… $833,370
Virginia Commonwealth University VCU will design, develop, and pilot novel and alternative synthetic route(s) to address primary cost drivers and remove Rifapentine carryover to subsequent… $1,679,645
The Global Health Impact Group LLC Provide technical support for an independent third party performance validation/evaluation of INEP's ELISA SARS-CoV-2 test and to conduct market… $59,930
Subrecipient not on record Minilab sampling testing and supervision plans, dissemination, workshop & final PMS report. $32,850
Show all 15

Quick answers

Who received award 7200AA19CA00025?

7200AA19CA00025 was awarded to The United States Pharmacopeial Convention, Inc. by Office of the Assistant Administrator (Bureau for Management) on September 27, 2019.

How much is award 7200AA19CA00025 worth?

$2,601,036,704 has been obligated on 7200AA19CA00025: $440,559,682 in federal funding and $2,160,477,022 in non-federal funding.

Which agency awarded 7200AA19CA00025?

Office of the Assistant Administrator (Bureau for Management) awarded 7200AA19CA00025, with funding from Bureau for Global Health (Washington Office).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login